Tate & Lyle earnings date
Tate & Lyle (TATE) Q2 2027 Earnings Report
CH:TATE Q2 2027 EPS Results
- Actual EPS
- GBP 0.18
- Consensus EPS
- GBP 0.21
- Beat/Miss
- Missed by -GBP 0.03
- One Year Ago EPS
- GBP 0.21
CH:TATE Q2 2027 Revenue Results
- Actual Revenue
- ―
- Expected Revenue
- GBP 1.02B
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2027
- Date
- 11/05/2026
- Time
- Before Open
- Conference Call
- Thursday, November 5, 2026
Tate & Lyle's next earnings date is estimated for May 27, 2027, based on past reporting schedules.
Q2 2027 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2027 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2027 Earnings Call Summary
The call was overall constructive and positive: Tate & Lyle returned to volume-led revenue growth, generated GBP 100 million of free cash flow, maintained full-year outlook and dividend progression, and reported strong momentum in Asia Pacific, the Americas, solutions, fiber and its new-business pipeline. These positives were tempered by a more challenging European market, muted consumer demand in Europe and North America, higher input-cost inflation, difficult upcoming customer contract negotiations and the continuing impact of the Middle East conflict.
Tate & Lyle is maintaining its outlook for the full year ending the 31st of March 2027, previously described as flat EBITDA, excluding the GBP 20 million bio-gums delay; H2 versus H1 is not expected to show a significant step-up, while the company expects to pass-through cost inflation through 2027 calendar year framework agreements and offset cost inflation through procurement activities and operational discipline. The bio-gum consolidation project is on track, and completion of the sale to Ingredion is expected in the second half of calendar year 2027; fiber is expected to accelerate over the next 12 to 18 months.
- Return to Volume-Led Revenue GrowthIn the first half, group revenue increased 1% and volume mix increased 3%. Excluding bulk sweeteners and co-products in Europe and tariff reimbursements in the U.S., revenue increased 2% and volume mix increased 4%.
- Strong Regional Performance Outside EuropeAsia Pacific delivered strong top-line momentum and the Americas performed robustly, helping offset a more challenging environment in Europe, the Middle East and Africa.
- Strategic Execution and Commercial ProgressManagement attributed the performance to execution of strategic actions to accelerate customer wins and commercial excellence, successful conversion of the new-business pipeline into volume-led growth, and continued productivity savings with strict cost discipline.
- Higher-Value Solutions WinsThe proportion of new business wins from solutions increased by 15 percentage points to 58%, supported by a growing pipeline focused on higher-value ingredients and customer solutions.
- Strong Cash Generation and Dividend IncreaseThe group generated GBP 100 million of free cash flow with cash conversion of 75%, in line with its long-term target. The interim dividend increased by 0.2p to 6.8p.
- Full-Year Outlook MaintainedManagement maintained its outlook for the full year ending March 31, 2027, with first-half profit in line with expectations.
- Bio-Gums Project On TrackThe bio-gum consolidation project is proceeding as anticipated and remains on track.
- Progress on Ingredion Transaction ApprovalsThe proposed sale of Tate & Lyle to Ingredion received written or verbal approval in six jurisdictions: Brazil, China, the U.K., South Korea, Tanzania and Zanzibar. Six approvals remain, and management continues to expect completion in the second half of calendar year 2027.
- Broad-Based Growth PipelineManagement said the pipeline of new business continues to grow, particularly around higher-value ingredients and solutions addressing affordability, health and wellness, cleaner labels, fiber fortification and other consumer trends.
- Fiber Growth MomentumThe company reported very strong take-up in fiber across all markets. Its broad base of soluble fibers with dietary-health accreditation is supporting customer formulations, and management expects fiber growth to accelerate over the next 12 to 18 months.
- Encouraging Asia Pacific and India TrendsAsia Pacific delivered very strong, broad-based volume-mix growth. China continued to show underlying growth, notably through expansion into foodservice, while India showed encouraging momentum as a new market.
- Americas and Latin America GrowthDespite the consumer environment in North America, the company grew volume and revenue, supported by a developing customer innovation pipeline. Latin America was described as performing solidly.
- EMEA Growth Excluding European Primary ProductsManagement reported good growth in EMEA despite the Middle Eastern crisis. Excluding the effect of the Primary Products business in Europe, volume mix in Europe grew 2%.
- Ongoing Productivity and Cost DisciplineThe company continued to deliver productivity savings and maintain strict cost discipline, while management emphasized continued focus on strategic execution, top-line growth and operational discipline.
CH:TATE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| May 27, 2027 | 2027 (Q4) | ―- | 0.19 | ― | ― |
| Nov 05, 2026 | 2027 (Q2) | 0.210.17 | 0.21 | -17.84% (-0.04) | |
| May 21, 2026 | 2026 (Q4) | 0.150.19 | 0.2 | -4.00% (-0.01) | |
| Nov 06, 2025 | 2026 (Q2) | 0.190.21 | 0.17 | 22.41% (+0.04) | |
| May 22, 2025 | 2025 (Q4) | ―0.20 | 0.22 | -7.83% (-0.02) | |
| Nov 07, 2024 | 2025 (Q2) | ―0.17 | 0.3 | -42.19% (-0.13) | |
| May 23, 2024 | 2024 (Q4) | ―0.22 | 0.17 | 24.71% (+0.04) | |
| Nov 09, 2023 | 2024 (Q2) | 0.270.30 | 0.26 | 15.33% (+0.04) | |
| May 25, 2023 | 2023 (Q4) | 0.230.17 | 0.14 | 28.89% (+0.04) | |
| Nov 10, 2022 | 2023 (Q2) | 0.190.26 | 0.3 | -13.00% (-0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
